Get the Stockscreener App
0.00
100.00%
-0.6063
After Hours:
.50
0.50
+
23 Andme Holding Co stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$0.6063
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$82.91M
Revenue:
$247.99M
Net Income/Loss:
$-521.97M
P/E Ratio:
0.00
EPS:
-1.11
Net Cash Flow:
$-194.28M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$10.81
23 Andme Holding Co Stock (ME) Company Profile
Name
23 Andme Holding Co
Sector
Industry
Phone
(650) 938-6300
Address
223 N. MATHILDA AVE., SUNNYVALE
Compare ME with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ME
23 Andme Holding Co
|
0.00 | 82.91M | 247.99M | -521.97M | -194.28M | -1.11 |
|
TMO
Thermo Fisher Scientific Inc
|
434.86 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
204.85 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
533.37 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
123.28 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
162.80 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-22 | Initiated | Berenberg | Buy |
| Sep-22-22 | Initiated | Cowen | Outperform |
| Nov-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Jul-12-21 | Initiated | Citigroup | Buy |
23 Andme Holding Co Stock (ME) Latest News
US judge won't block 23andMe bankruptcy sale to co-founder - Reuters
23andMe Sale to Proceed as California Continues Appeal (Correct) - Bloomberg Law News
Judge briefly pauses 23andMe bankruptcy sale amid California's appeal - Reuters
23andMe Privacy Reviewer Defends WilmerHale as Choice of Counsel - Bloomberg Law News
Calif. Fails To Pause 23andMe's Sale During Appeal - Law360
California fails to stop 23andMe founder from re-acquiring company - Reuters
Bankruptcy Court Approves Sale of 23andMe - The HIPAA Journal
California Appeals 23andMe Genetic Data Sale in Bankruptcy Case - Bloomberg Law News
23andMe Co-Founder Anne Wojcicki Wins Back Company In $305M Deal, Beating Regeneron’s Bid - Stocktwits
Judge OKs sale of 23andMe in bankruptcy case - WWLP
23andMe wins court OK for $305M asset sale; equity risk flagged | ME SEC FilingForm 8-K - Stock Titan
23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation - GlobeNewswire
Judge OKs 23AndMe's $305M Genetic Data Asset Sale - Law360
23andMe Wins Approval of $305 Million Genetic Data Asset Sale - Bloomberg Law News
23andMe Seeks To Ease Concerns Over Sale To Founder - Law360
23andMe Bankruptcy Judge Rejects Texas Effort to Halt Data Sale - Bloomberg Law News
DNA testing firm 23andMe fined £2.31m for ‘serious security failings’ - MSN
23andMe fined millions by watchdog after ‘profoundly damaging’ cyber attack exposing genetic data - lbc.co.uk
Anne Wojcicki on genetic privacy, data security and the money behind her bid for 23andMe - The Business Journals
23andMe Fined £2.31 Million by UK Over Genetic Data Leak - Bloomberg
23andMe Names New Buyer, Pa. Retirees Sue Over Ch. 9 Sale - Law360
23andme founder-led group outbids Regeneron for company - BioWorld MedTech
Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer - Reuters
Regeneron Pharmaceuticals says declined to submit new bid on 23andMe exceeding original $256 mln - MarketScreener
23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing company - AllSides
23andMe co-founder Anne Wojcicki wins back genetic test company in bankruptcy court saleBizwomen - The Business Journals
23andMe Holding Acquired by TTAM Research Institute - TipRanks
23andMe Founder's $305M Bid Buys Back Co. In Ch. 11 Sale - Law360
23andMe (MEHCQ) Acquired by TTAM for $305M - GuruFocus
23andMe Co-Founder Wins Auction for Genetic Data - Bloomberg
23andMe's founder Anne Wojcicki wins bid for bankrupt DNA testing firm - MarketScreener
23andMe sold to non-profit headed by co-founder Anne Wojcicki - Seeking Alpha
Anne Wojcicki wins back 23andMe in bankruptcy court saleSan Francisco Business Times - The Business Journals
23andMe confirms sale of business to TTAM Research Institute for $305M - TipRanks
23andMe's founder Anne Wojcicki wins bid for DNA testing firm - marketscreener.com
23andMe assets to be sold to founder’s nonprofit for $305 million - Investing.com
23andMe Reaches Agreement for Sale of Business to TTAM - GlobeNewswire
Anne Wojcicki Wins Bidding For 23Andme- WSJ - marketscreener.com
23andMe Ombudsman Not Confident Sale Is Lawful - Law360
Ocasio-Cortez leads congressional call for genetic data safeguards amid 23andMe bankruptcy - Bronx Times
23andMe Privacy Ombudsman Urges User Consent Pre-Data Sale (1) - Bloomberg Law News
Senate holds hearing on 23andMe, concerns over company selling customers’ data (Video) - Social News XYZ
IP, Health Law Scholars Object To 23andMe Ch. 11 Data Sale - Law360
23andme genetic privacy concerns garner Congressional scrutiny - BioWorld MedTech
23andMe Holding Co. SEC 10-K Report - TradingView
Senator Calls For 23AndMe Customers To Sue Company 'Into Oblivion' - Newsweek
Senate holds hearing on 23andMe, concerns over company selling customers' data - CBS News
States Sue To Block 23andMe From Selling DNA Data In Ch. 11 - Law360
23andMe (MEHCQ) Faces Legal Challenge Over Genetic Data Sale - GuruFocus
23andMe Privacy Reviewer’s Law Firm Discloses Work for Regeneron - Bloomberg Law News
US states sue 23andMe to protect customers' private data - marketscreener.com
23 Andme Holding Co Stock (ME) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):